Your new post is loading...
One regimen showed an effectiveness of 90% when participants received a half dose, followed by a full dose at least one month apart.
|
Scooped by Benoit Lamy |
Scoop.it!
No comment yet.
Sign up to comment
After Pfizer-BioNTech and Moderna, Oxford-AstraZeneca is announcing the results of the trials of its vaccine.